Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- CHPT -28.8%, AMSWA -9.0%, AMAT -7.1%, CMP -5.4%, BJ -4.9%, DLB -2.3%, WWD -2.1%, BKE -1.2%
Other news:
- VIGL -11.1% (Reports Positive Interim Data from Phase 2 IGNITE Proof-of-Concept Clinical Trial Evaluating Iluzanebart (VGL101) as a Treatment for ALSP and from Ongoing Natural History Study ILLUMINATE)
- NAPA -3.8% (to acquire Sonoma-Cutrer Vineyards from Brown-Forman Corporation (BF.B) for approximately $400 mln in cash and stock)
- EVGO -3.0% (lower in sympathy with CHPT; announces joint promotion to offer special charging rates to drivers renting any EV model at Hertz locations)
- NI -2.7% (announced the unsuccessful final remarketing of its Series C Mandatory Convertible Preferred Stock with a liquidation preference of $1,000 per share)
- KLAC -2.4% (lower in sympathy with AMAT)
- LRCX -1.7% (lower in sympathy with AMAT)
- BLNK -1.4% (lower in sympathy with CHPT)
Analyst comments:
- ABNB -0.6% (downgraded to In-Line from Outperform at Evercore ISI)